Benralizumab
Cat. No.: IBDI-431724
Benralizumab (MEDI-563) is an interleukin-5 receptor α (IL-5Rα)-directed cytolytic monoclonal antibody that induces direct, rapid and nearly complete depletion of eosinophils via enhanced antibody-dependent cell-mediated cytotoxicity. Benralizumab can be used for severe eosinophilic asthma.
Product Details
| Target |
Interleukin Related | Apoptosis |
| Appearance |
Liquid |
| Synonyms |
MEDI-563, BIW-8405 |
| Purity |
99.1% |
Storage & Handling
| Storage |
Please store the product under the recommended conditions in the Certificate of Analysis. |
| Regulatory Status |
This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. |
! For research use only, not intended for any clinical use.
